美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco S&P SmallCap Health Care ETF

52.87

-0.6339-1.18%

盤後：52.930.0561+0.11%16:15 EDT

成交量：7,428

成交額：39.34萬

市值：1.83億

市盈率：- -

高：53.12

開：53.00

低：52.81

收：53.51

52周最高：56.45

52周最低：39.08

股本：347.00萬

流通股本：347.00萬

量比：0.24

換手率：0.21%

股息：0.00

股息率：0.01%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

阿爾凱默斯 - Alixorexton在首次給藥九個月後，於第24周在MWT和ESS上顯示出持續改善

高盛：日本企業併購活動尚處初期

高盛：日本企業併購活動正處於「初期階段」

阿爾凱默斯與安尼爾終止授權仿製藥供應協議

阿爾凱默斯與安尼爾協議終止後，無需承擔罰金或額外義務——SEC文件披露

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/PSCH/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":52.8739,"timestamp":1789761600000,"preClose":53.5078,"halted":0,"volume":7428,"hourTrading":{"tag":"盘后","latestPrice":52.93,"preClose":52.8739,"latestTime":"16:15 EDT","volume":11,"amount":582.1295,"timestamp":1789762500303,"change":0.0561,"changeRate":0.001061,"amplitude":0},"delay":0,"changeRate":-0.011846870923491605,"floatShares":3470000,"shares":3470000,"eps":0,"marketStatus":"休市中","change":-0.6339,"latestTime":"09-18 16:00:00 EDT","open":53,"high":53.1235,"low":52.805,"amount":393369,"amplitude":0.005952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":53.5078,"sharesOutstanding":3220000,"nav":53.50055,"aum":185646908.5,"dividendRate":0.000057,"bidAskSpread":0.001764,"preHourTrading":{"tag":"盘前","latestPrice":53.5078,"preClose":53.5078,"latestTime":"04:00 EDT","volume":1,"amount":53.5078,"timestamp":1789718420453,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":52.93,"preClose":52.8739,"latestTime":"16:15 EDT","volume":11,"amount":582.1295,"timestamp":1789762500303,"change":0.0561,"changeRate":0.001061,"amplitude":0},"volumeRatio":0.23913771406273396,"impliedVol":0.1092,"impliedVolPercentile":0.7251},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3470000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.23913771406273396,"shares":3470000,"dividePrice":0.003,"high":53.1235,"amplitude":0.005952,"preClose":53.5078,"low":52.805,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":52.8739,"eps":0,"divideRate":0.000057,"volume":7428,"delay":0,"ttmEps":0,"open":53,"prevYearClose":44.0553,"prevWeekClose":52.9516,"prevMonthClose":54.61,"prevQuarterClose":52.3666,"fiveDayClose":52.9516,"twentyDayClose":55.2709,"sixtyDayClose":50.3917},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187620650","title":"阿爾凱默斯 - Alixorexton在首次給藥九個月後，於第24周在MWT和ESS上顯示出持續改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1187620650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187620650?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:03","pubTimestamp":1783940597,"startTime":"0","endTime":"0","summary":"阿尔凯默斯公司宣布，其候选药物Alixorexton在首次给药九个月后，于临床试验的第24周评估中，在维持清醒测试和嗜睡量表两项关键指标上均表现出持续性的改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","ALKS","PSCH","MEDX","PSIL","FBT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945691","title":"高盛：日本企業併購活動尚處初期","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945691","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945691?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 13:08","pubTimestamp":1783573703,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MSSM","BK4585","JSMD","TMFS","SMCO","SPMD","BK4588","SCDS","SYLD","PSCH","DEEP","CAFG","QQQS","IJS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945339","title":"高盛：日本企業併購活動正處於「初期階段」","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945339","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945339?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 12:55","pubTimestamp":1783572940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","MSSM","SPMD","SYLD","IJS","DEEP","TMFS","SMCO","QQQS","CAFG","PSCH","JSMD","SCDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160787890","title":"阿爾凱默斯與安尼爾終止授權仿製藥供應協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1160787890","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160787890?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:06","pubTimestamp":1783512380,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，阿尔凯默斯公司与其合作伙伴安尼尔公司已共同决定，自2026年7月6日起，终止双方此前达成的授权仿制药产品供应协议。\n这一变动标志着两家公司在该特定产品合作上的正式分道扬镳。协议的终止将影响相关仿制药未来的市场供应格局。文件披露了这一商业安排的调整，但未进一步阐述终止协议的具体原因或后续财务影响。\n市场参与者将密切关注此举对阿尔凯默斯业务管线及收入构成的潜在影响。同时，安尼尔公司的产品组合也可能因此次合作终止而面临调整。此次战略调整的长期影响，仍有待后续观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","MEDX","BK4139","PSIL","ALKS","PSCH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155767412","title":"阿爾凱默斯與安尼爾協議終止後，無需承擔罰金或額外義務——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1155767412","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155767412?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:06","pubTimestamp":1783512372,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件，阿尔凯默斯与安尼尔在协议终止后，双方均无需支付任何罚金，也无需履行进一步的义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","FBT","ALKS","MEDX","IBRN","PSCH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":45,"code":"91000000","status":"200"}]}}